56-60
Turnaround times in breast cancer: From screening to diagnosis to treatment
Authors: Kaylene J Logan, Patrice M. Weiss, Catherine Hagan-Aylor, Bob Herbertson

Number of views: 620
Objective: To compare our institution with national benchmark times, and identify rate-limiting
steps in the process by conducte a retrospective review of the turnaround times in 2009 at the
Carilion Clinic Breast Care Center (CCBCC). To evaluate patient satisfaction with the turn around
times. Methods: A retrospective chart review was performed to evaluate the time intervals
from abnormal screening mammogram to diagnostic mammogram, diagnostic mammogram to
biopsy, biopsy to MRI, and MRI to surgery of all patients seen for breast cancer in 2009. A patient
survey was mailed out to all patients (131) managed from abnormal screening to surgery in 2009,
assessing their satisfaction with the turnaround times from screening mammogram to call back,
call back to diagnostic mammogram, diagnostic mammogram to biopsy, biopsy to results call,
biopsy result to MRI appointment, MRI appointment to surgery consult, and surgery consult to
surgery; and assessing possible reasons why patients may perceive the process to be delayed.
The MEANS procedure was applied to evaluate the turnaround times, and a Box and Whisker Plot
statistical comparison was made between patient satisfaction and turnaround times. Results: The
mean turnaround time at the CCBCC in 2009 from abnormal screening mammogram to surgery was
45 d. This falls within the 75th %ile of the National Quality Measures for Breast Centers (NQMBC),
established by the National Consortium of Breast Centers (NCBC). Of 131 surveys mailed out, 57
were returned (44%). The patient satisfaction rates for each interval ranged from 96%-100%, with
an overall satisfaction rate of 98% for abnormal screening mammogram to surgery. Discussion:
The CCBCC ranks at the 75%ile in overall turnaround times; however, this turnaround time
included an interval of MRI, not previously measured in NQMBC benchmark. Rate-limiting steps
were identified as the time from screening mammogram to diagnostic mammogram, and biopsy
to surgery-specifically, the sub-interval MRI to surgery. Since 2009, the CCBCC has already
improved the process for obtaining insurance approval and preauthorization for MRIs; and has
added an additional breast surgeon to share the burden of benign cases, and a nurse practitioner
to see post-op and follow up patients, improving the accessibility to the primary breast surgeon
specialist. Consideration should be given to future time interval studies that evaluate breast
cancer turnaround time including MRI to help establish benchmarks.